13F
中

UTHR UNITED THERAPEUTICS CORP

2026Q1 · CUSIP 91307C102 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
841
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
281
Δ whales
-2
Inst. holding value
$24.4B
New positions
114
Closed positions
103
Price momentum (1Q)
+17.5%
Put / Call
21/20

Breadth history (34 quarters)

2018Q1: Δ-21 · h=372 2018Q2: Δ-6 · h=366 2018Q3: Δ-4 · h=362 2018Q4: Δ-6 · h=356 2019Q1: Δ+15 · h=371 2019Q2: Δ-53 · h=318 2019Q3: Δ-20 · h=298 2019Q4: Δ+16 · h=314 2020Q1: Δ-14 · h=300 2020Q2: Δ+46 · h=346 2020Q3: Δ-16 · h=330 2020Q4: Δ+21 · h=351 2021Q1: Δ+36 · h=387 2021Q2: Δ+9 · h=396 2021Q3: Δ+24 · h=420 2021Q4: Δ-9 · h=411 2022Q1: Δ+13 · h=424 2022Q2: Δ+43 · h=467 2022Q3: Δ-9 · h=458 2022Q4: Δ+55 · h=513 2023Q1: Δ-8 · h=505 2023Q2: Δ-32 · h=473 2023Q3: Δ+36 · h=509 2023Q4: Δ+27 · h=536 2024Q1: Δ-15 · h=521 2024Q2: Δ+44 · h=565 2024Q3: Δ+55 · h=620 2024Q4: Δ+49 · h=669 2025Q1: Δ-2 · h=667 2025Q2: Δ+0 · h=667 2025Q3: Δ+34 · h=701 2025Q4: Δ+129 · h=830 2026Q1: Δ+11 · h=841 2018Q1: holders=372 2018Q2: holders=366 2018Q3: holders=362 2018Q4: holders=356 2019Q1: holders=371 2019Q2: holders=318 2019Q3: holders=298 2019Q4: holders=314 2020Q1: holders=300 2020Q2: holders=346 2020Q3: holders=330 2020Q4: holders=351 2021Q1: holders=387 2021Q2: holders=396 2021Q3: holders=420 2021Q4: holders=411 2022Q1: holders=424 2022Q2: holders=467 2022Q3: holders=458 2022Q4: holders=513 2023Q1: holders=505 2023Q2: holders=473 2023Q3: holders=509 2023Q4: holders=536 2024Q1: holders=521 2024Q2: holders=565 2024Q3: holders=620 2024Q4: holders=669 2025Q1: holders=667 2025Q2: holders=667 2025Q3: holders=701 2025Q4: holders=830 2026Q1: holders=841 -129 -64.5 +0 +64.5 +129 268576884 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 14 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 3% +17.5% —
2025Q3 Top 8% +1.8% +19.5%
2024Q4 Top 10% -18.1% -16.0%
2024Q3 Top 3% +0.5% -14.1%
2024Q2 Top 4% +20.3% +18.6%
2023Q4 Top 20% +27.7% +62.3%
2023Q3 Top 3% -5.5% +21.2%
2022Q4 Top 6% -13.8% -8.6%

Options Sentiment

Put holders
21
QoQ: +9
Call holders
20
QoQ: +9

See methodology →

Fundamentals

PE (TTM)
19.4
EPS (TTM)
$27.05
EPS YoY
+7.8%
Revenue (TTM)
$3.2B
Revenue YoY
+5.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $467M 2022-09-30: $516M 2022-12-31: $492M 2023-03-31: $507M 2023-06-30: $597M 2023-09-30: $609M 2023-12-31: $615M 2024-03-31: $678M 2024-06-30: $715M 2024-09-30: $749M 2024-12-31: $736M 2025-03-31: $794M 2025-06-30: $799M 2025-09-30: $800M 2025-12-31: $790M 2026-03-31: $782M 2022-06-30: EPS 2.41 2022-09-30: EPS 4.91 2022-12-31: EPS 2.65 2023-03-31: EPS 4.86 2023-06-30: EPS 5.24 2023-09-30: EPS 5.38 2023-12-31: EPS 4.33 2024-03-31: EPS 6.17 2024-06-30: EPS 5.85 2024-09-30: EPS 6.39 2024-12-31: EPS 6.23 2025-03-31: EPS 6.63 2025-06-30: EPS 6.41 2025-09-30: EPS 7.16 2025-12-31: EPS 7.66 2026-03-31: EPS 5.82 0M 400M 800M $M 0.00 4.21 8.43 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 15 2023-03-31: PE 14.62023-06-30: PE 13.12023-09-30: PE 12.52023-12-31: PE 10.82024-03-31: PE 132024-06-30: PE 14.82024-09-30: PE 162024-12-31: PE 152025-03-31: PE 12.22025-06-30: PE 12.22025-09-30: PE 17.62025-12-31: PE 172026-03-31: PE 21 10 16 22 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)